134 related articles for article (PubMed ID: 10471096)
41. The effect of streptozotocin-induced diabetes on dopamine2, serotonin1A and serotonin2A receptors in the rat brain.
Sumiyoshi T; Ichikawa J; Meltzer HY
Neuropsychopharmacology; 1997 Mar; 16(3):183-90. PubMed ID: 9138434
[TBL] [Abstract][Full Text] [Related]
42. Modification of 5-HT2 receptor mediated behaviour in the rat by oleamide and the role of cannabinoid receptors.
Cheer JF; Cadogan AK; Marsden CA; Fone KC; Kendall DA
Neuropharmacology; 1999 Apr; 38(4):533-41. PubMed ID: 10221757
[TBL] [Abstract][Full Text] [Related]
43. Effect of antipsychotic drugs on extracellular serotonin levels in rat medial prefrontal cortex and nucleus accumbens.
Ichikawa J; Kuroki T; Dai J; Meltzer HY
Eur J Pharmacol; 1998 Jun; 351(2):163-71. PubMed ID: 9686999
[TBL] [Abstract][Full Text] [Related]
44. Evidence for presynaptic location of inhibitory 5-HT1D beta-like autoreceptors in the guinea-pig brain cortex.
Bühlen M; Fink K; Böing C; Göthert M
Naunyn Schmiedebergs Arch Pharmacol; 1996 Feb; 353(3):281-9. PubMed ID: 8692282
[TBL] [Abstract][Full Text] [Related]
45. Serotonin, via 5-HT2A receptors, increases EPSCs in layer V pyramidal cells of prefrontal cortex by an asynchronous mode of glutamate release.
Aghajanian GK; Marek GJ
Brain Res; 1999 Apr; 825(1-2):161-71. PubMed ID: 10216183
[TBL] [Abstract][Full Text] [Related]
46. Dysregulated 5-HT(2A) receptor binding in postmortem frontal cortex of schizophrenic subjects.
Muguruza C; Moreno JL; Umali A; Callado LF; Meana JJ; González-Maeso J
Eur Neuropsychopharmacol; 2013 Aug; 23(8):852-64. PubMed ID: 23176747
[TBL] [Abstract][Full Text] [Related]
47. Chronic fluoxetine differentially affects 5-hydroxytryptamine (2A) receptor signaling in frontal cortex, oxytocin- and corticotropin-releasing factor-containing neurons in rat paraventricular nucleus.
Damjanoska KJ; Van de Kar LD; Kindel GH; Zhang Y; D'Souza DN; Garcia F; Battaglia G; Muma NA
J Pharmacol Exp Ther; 2003 Aug; 306(2):563-71. PubMed ID: 12721328
[TBL] [Abstract][Full Text] [Related]
48. Repeated DOI and SR 46349B treatments do not affect elevated plus-maze anxiety despite opposite effects on cortical 5-HT2A receptors.
Chaouloff F; Kulikov A; Mormède P
Eur J Pharmacol; 1997 Sep; 334(1):25-9. PubMed ID: 9346323
[TBL] [Abstract][Full Text] [Related]
49. In vitro and in vivo irreversible blockade of cortical S2 serotonin receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline: a technique for investigating S2 serotonin receptor recovery.
Battaglia G; Norman AB; Newton PL; Creese I
J Neurochem; 1986 Feb; 46(2):589-93. PubMed ID: 2934516
[TBL] [Abstract][Full Text] [Related]
50. Possible role of protein kinase C in regulation of 5-hydroxytryptamine 2A receptors in rat brain.
Rahimian R; Hrdina PD
Can J Physiol Pharmacol; 1995 Dec; 73(12):1686-91. PubMed ID: 8834481
[TBL] [Abstract][Full Text] [Related]
51. 5-HT2 receptor regulation of acetylcholine release induced by dopaminergic stimulation in rat striatal slices.
Ramírez MJ; Cenarruzabeitia E; Lasheras B; Del Rio J
Brain Res; 1997 May; 757(1):17-23. PubMed ID: 9200494
[TBL] [Abstract][Full Text] [Related]
52. 5-Hydroxytryptamine receptor-mediated phosphoinositide hydrolysis in canine cultured tracheal smooth muscle cells.
Yang CM; Yo YL; Hsieh JT; Ong R
Br J Pharmacol; 1994 Mar; 111(3):777-86. PubMed ID: 8019756
[TBL] [Abstract][Full Text] [Related]
53. Radiolabelling of the human 5-HT2A receptor with an agonist, a partial agonist and an antagonist: effects on apparent agonist affinities.
Sleight AJ; Stam NJ; Mutel V; Vanderheyden PM
Biochem Pharmacol; 1996 Jan; 51(1):71-6. PubMed ID: 8534270
[TBL] [Abstract][Full Text] [Related]
54. Activation of 5-HT2A receptors impairs response control of rats in a five-choice serial reaction time task.
Koskinen T; Ruotsalainen S; Puumala T; Lappalainen R; Koivisto E; Männistö PT; Sirviö J
Neuropharmacology; 2000 Jan; 39(3):471-81. PubMed ID: 10698013
[TBL] [Abstract][Full Text] [Related]
55. Agonist-induced serotonin 2A receptor desensitization in the rat frontal cortex and hypothalamus.
Damjanoska KJ; Heidenreich BA; Kindel GH; D'Souza DN; Zhang Y; Garcia F; Battaglia G; Wolf WA; Van de Kar LD; Muma NA
J Pharmacol Exp Ther; 2004 Jun; 309(3):1043-50. PubMed ID: 14976228
[TBL] [Abstract][Full Text] [Related]
56. Evidence that 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-induced hyperthermia in rats is mediated by stimulation of 5-HT2A receptors.
Mazzola-Pomietto P; Aulakh CS; Wozniak KM; Hill JL; Murphy DL
Psychopharmacology (Berl); 1995 Jan; 117(2):193-9. PubMed ID: 7753967
[TBL] [Abstract][Full Text] [Related]
57. An immunocapture/scintillation proximity analysis of G alpha q/11 activation by native serotonin (5-HT)2A receptors in rat cortex: blockade by clozapine and mirtazapine.
Mannoury La Cour C; Chaput C; Touzard M; Millan MJ
Synapse; 2009 Feb; 63(2):95-105. PubMed ID: 19016481
[TBL] [Abstract][Full Text] [Related]
58. Electrophysiological evidence for a functional interaction between 5-HT1A and 5-HT2A receptors in the rat medial prefrontal cortex: an iontophoretic study.
Ashby CR; Edwards E; Wang RY
Synapse; 1994 Jul; 17(3):173-81. PubMed ID: 7974200
[TBL] [Abstract][Full Text] [Related]
59. BIMT 17, a 5-HT1A receptor agonist/5-HT2A receptor antagonist, directly activates postsynaptic 5-HT inhibitory responses in the rat cerebral cortex.
Borsini F; Ceci A; Bietti G; Donetti A
Naunyn Schmiedebergs Arch Pharmacol; 1995 Sep; 352(3):283-90. PubMed ID: 8584043
[TBL] [Abstract][Full Text] [Related]
60. Involvement of 5-HT(1B/1D) and 5-HT2A receptors in 5-HT-induced contraction of endothelium-denuded rabbit epicardial coronary arteries.
Ellwood AJ; Curtis MJ
Br J Pharmacol; 1997 Nov; 122(5):875-84. PubMed ID: 9384503
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
